PHGE · Categories · Form 4
PHGE - SEC Form 4 insider transactions
BiomX Inc. (PHGE) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for PHGE
- SEC Form 4 filed by Yeganeh Reuven4 - BiomX Inc. (0001739174) (Issuer)
- Director Yeganeh Reuven sold $3,350,000 worth of shares (670,000 units at $5.00) and converted options into 670,000 shares (SEC Form 4)4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by *Director by Deputization Flynn James E4 - BiomX Inc. (0001739174) (Issuer)
- Amendment: SEC Form 4 filed by Director Merril Gregory Louis4/A - BiomX Inc. (0001739174) (Issuer)
- Amendment: Chief Development Officer Bassan Merav was granted 79,597 shares (SEC Form 4)4/A - BiomX Inc. (0001739174) (Issuer)
- Amendment: Chief Executive Officer Solomon Jonathan Eitan was granted 126,748 shares (SEC Form 4)4/A - BiomX Inc. (0001739174) (Issuer)
- Amendment: SEC Form 4 filed by Director Goodman Jesse4/A - BiomX Inc. (0001739174) (Issuer)
- Amendment: SEC Form 4 filed by Director Williams Eddie4/A - BiomX Inc. (0001739174) (Issuer)
- Amendment: SEC Form 4 filed by Director Moses Alan Charles4/A - BiomX Inc. (0001739174) (Issuer)
- Amendment: SEC Form 4 filed by Director Leff Jonathan S4/A - BiomX Inc. (0001739174) (Issuer)
- Amendment: SEC Form 4 filed by Director Blum Susan4/A - BiomX Inc. (0001739174) (Issuer)
- Amendment: SEC Form 4 filed by Director Greig Russell4/A - BiomX Inc. (0001739174) (Issuer)
- Amendment: Chief Financial Officer Wolfson Marina was granted 68,545 shares (SEC Form 4)4/A - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by *Director by Deputization Flynn James E4 - BiomX Inc. (0001739174) (Issuer)
- Chief Financial Officer Wolfson Marina was granted 68,545 shares (SEC Form 4)4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Director Leff Jonathan S4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Director Goodman Jesse4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Director Greig Russell4 - BiomX Inc. (0001739174) (Issuer)
- Chief Development Officer Bassan Merav was granted 79,597 shares (SEC Form 4)4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Director Merril Gregory Louis4 - BiomX Inc. (0001739174) (Issuer)
- Chief Executive Officer Solomon Jonathan Eitan was granted 126,748 shares (SEC Form 4)4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Director Moses Alan Charles4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Director Blum Susan4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Director Williams Eddie4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Large owner Cystic Fibrosis Foundation4 - BiomX Inc. (0001739174) (Issuer)
- *Director by Deputization Flynn James E exercised 706,498 shares at a strike of $0.93 (SEC Form 4)4 - BiomX Inc. (0001739174) (Issuer)
- Chief Business Officer Oron Assaf was granted 25,804 shares (SEC Form 4)4 - BiomX Inc. (0001739174) (Issuer)
- Chief Executive Officer Solomon Jonathan Eitan was granted 50,556 shares, increasing direct ownership by 2,022% to 53,056 units (SEC Form 4)4 - BiomX Inc. (0001739174) (Issuer)
- Chief Development Officer Bassan Merav was granted 31,749 shares (SEC Form 4)4 - BiomX Inc. (0001739174) (Issuer)
- *Director by Deputization Flynn James E converted options into 11,766,000 shares (SEC Form 4)4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by *Director by Deputization Flynn James E4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Director Blum Susan4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Director Greig Russell4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Chief Development Officer Bassan Merav4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Wolfson Marina4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Solomon Jonathan Eitan4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Director Leff Jonathan S4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Director Goodman Jesse4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Director Merril Gregory Louis4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Director Williams Eddie4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Chief Business Officer Oron Assaf4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Director Moses Alan Charles4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by *Director by Deputization Flynn James E4 - BiomX Inc. (0001739174) (Issuer)
- Orbimed Israel Biofund Gp Limited Partnership exercised 9,280,408 in-the-money shares at a strike of $0.24 and sold $9,280 worth of shares (24,344 units at $0.38) (SEC Form 4)4 - BiomX Inc. (0001739174) (Issuer)
- Cystic Fibrosis Foundation exercised 4,778,265 in-the-money shares at a strike of $0.00, increasing direct ownership by 105% to 9,330,580 units (SEC Form 4)4 - BiomX Inc. (0001739174) (Issuer)
- Flynn James E was granted 6,110,098 shares (SEC Form 4)4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Orbimed Israel Biofund Gp Limited Partnership4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Wolfson Marina4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Bassan Merav4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Solomon Jonathan Eitan4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Oron Assaf4 - BiomX Inc. (0001739174) (Issuer)
- Oron Assaf sold $4,072 worth of shares (10,914 units at $0.37), closing all direct ownership in the company (SEC Form 4)4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Bassan Merav4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Wolfson Marina4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Solomon Jonathan Eitan4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Oron Assaf4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Williams Eddie4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Marks Jason M.4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Dambach Michael E.4 - BiomX Inc. (0001739174) (Issuer)
- SEC Form 4 filed by Oron Assaf4 - BiomX Inc. (0001739174) (Issuer)